Search research articles
Contact Us
Filters
Showing results (151-160 of 179) with videos related to
Page
of 18
Sort By:
American Journal of Hematology
|
May 1, 1988
Transmission of human immunodeficiency virus to sexual partners of hemophiliacs
M L Smiley, G C White, P Becherer, et al.
Thrombosis and Haemostasis
|
April 2, 1999
Utilization of previously treated patients (PTPs), noninfected patients (NIPs), and previously untreated patients (PUPs) in the evaluation of new factor VIII and factor IX concentrates. Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
G C White, D DiMichele, K Mertens, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 5, 2009
Rap1b is critical for glycoprotein VI-mediated but not ADP receptor-mediated alpha2beta1 activation
Z Wang, S P Holly, M K Larson, et al.
Lancet (London, England)
|
March 15, 1986
HTLV-III seroconversion associated with heat-treated factor VIII concentrate
G C White, T J Matthews, K J Weinhold, et al.
Blood
|
December 1, 1982
Chronic hepatitis in patients with hemophilia A: histologic studies in patients with intermittently abnormal liver function tests
G C White, K D Zeitler, H R Lesesne, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 7, 2005
B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study
C M Kessler, J C Gill, G C White, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1986
Hemophilic patients with an inhibitor to factor VIII treated with high dose factor VIII concentrate. Results of a collaborative study for the evaluation of factor VIII inhibitor titer, recovery and half life of infused factor VIII
Y Sultan, G C White, A Aronstam, et al.
Annals of Surgery
|
April 1, 1990
Wound infection rates after invasive procedures in HIV-1 seropositive versus HIV-1 seronegative hemophiliacs
J L Buehrer, D J Weber, A A Meyer, et al.
American Journal of Hematology
|
August 1, 1991
Hepatocellular carcinoma in hemophilia
M Colombo, P M Mannucci, D B Brettler, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 1, 2004
Phase I study of a novel recombinant human soluble thrombomodulin, ART-123
S Moll, C Lindley, S Pescatore, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 179) with videos related to
Sort By:
Page
of 18
American Journal of Hematology
|
May 1, 1988
Transmission of human immunodeficiency virus to sexual partners of hemophiliacs
M L Smiley, G C White, P Becherer, et al.
Thrombosis and Haemostasis
|
April 2, 1999
Utilization of previously treated patients (PTPs), noninfected patients (NIPs), and previously untreated patients (PUPs) in the evaluation of new factor VIII and factor IX concentrates. Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
G C White, D DiMichele, K Mertens, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 5, 2009
Rap1b is critical for glycoprotein VI-mediated but not ADP receptor-mediated alpha2beta1 activation
Z Wang, S P Holly, M K Larson, et al.
Lancet (London, England)
|
March 15, 1986
HTLV-III seroconversion associated with heat-treated factor VIII concentrate
G C White, T J Matthews, K J Weinhold, et al.
Blood
|
December 1, 1982
Chronic hepatitis in patients with hemophilia A: histologic studies in patients with intermittently abnormal liver function tests
G C White, K D Zeitler, H R Lesesne, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 7, 2005
B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study
C M Kessler, J C Gill, G C White, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1986
Hemophilic patients with an inhibitor to factor VIII treated with high dose factor VIII concentrate. Results of a collaborative study for the evaluation of factor VIII inhibitor titer, recovery and half life of infused factor VIII
Y Sultan, G C White, A Aronstam, et al.
Annals of Surgery
|
April 1, 1990
Wound infection rates after invasive procedures in HIV-1 seropositive versus HIV-1 seronegative hemophiliacs
J L Buehrer, D J Weber, A A Meyer, et al.
American Journal of Hematology
|
August 1, 1991
Hepatocellular carcinoma in hemophilia
M Colombo, P M Mannucci, D B Brettler, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 1, 2004
Phase I study of a novel recombinant human soluble thrombomodulin, ART-123
S Moll, C Lindley, S Pescatore, et al.
Page
of 18